vs
PATHWARD FINANCIAL, INC.（CASH）与Tarsus Pharmaceuticals, Inc.（TARS）财务数据对比。点击上方公司名可切换其他公司
PATHWARD FINANCIAL, INC.的季度营收约是Tarsus Pharmaceuticals, Inc.的1.8倍（$276.3M vs $151.7M），PATHWARD FINANCIAL, INC.净利率更高（26.4% vs -5.5%，领先31.9%），过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高（134.4% vs 21.0%）
Pathward Financial, Inc.是一家总部位于美国的银行及金融服务企业，其前身为Meta金融集团旗下相关业务主体，2022年母公司将“Meta”商标出售给Meta Platforms后，正式启用现有名称。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司，专注于眼科、皮肤科等专科领域创新疗法的研发和商业化，主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症，核心市场为美国。
CASH vs TARS — 直观对比
营收规模更大
CASH
是对方的1.8倍
$151.7M
净利率更高
CASH
高出31.9%
-5.5%
两年增速更快
TARS
近两年复合增速
21.0%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $276.3M | $151.7M |
| 净利润 | $72.9M | $-8.4M |
| 毛利率 | — | — |
| 营业利润率 | — | -5.3% |
| 净利率 | 26.4% | -5.5% |
| 营收同比 | — | 128.4% |
| 净利润同比 | — | 63.8% |
| 每股收益（稀释后） | $3.35 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CASHTARS
| Q1 26 | $276.3M | — | ||
| Q4 25 | $173.1M | $151.7M | ||
| Q3 25 | $186.7M | $118.7M | ||
| Q2 25 | $195.8M | $102.7M | ||
| Q1 25 | $274.8M | $78.3M | ||
| Q4 24 | $182.6M | $66.4M | ||
| Q3 24 | $179.5M | $48.1M | ||
| Q2 24 | $188.6M | $40.8M |
净利润CASHTARS
| Q1 26 | $72.9M | — | ||
| Q4 25 | $35.2M | $-8.4M | ||
| Q3 25 | $38.8M | $-12.6M | ||
| Q2 25 | $42.1M | $-20.3M | ||
| Q1 25 | $75.0M | $-25.1M | ||
| Q4 24 | $30.0M | $-23.1M | ||
| Q3 24 | $33.5M | $-23.4M | ||
| Q2 24 | $44.9M | $-33.3M |
营业利润率CASHTARS
| Q1 26 | — | — | ||
| Q4 25 | 24.6% | -5.3% | ||
| Q3 25 | 25.9% | -12.2% | ||
| Q2 25 | 24.1% | -21.6% | ||
| Q1 25 | 33.2% | -33.5% | ||
| Q4 24 | 19.8% | -36.8% | ||
| Q3 24 | 20.9% | -52.3% | ||
| Q2 24 | 27.1% | -81.6% |
净利率CASHTARS
| Q1 26 | 26.4% | — | ||
| Q4 25 | 20.3% | -5.5% | ||
| Q3 25 | 20.8% | -10.6% | ||
| Q2 25 | 21.5% | -19.8% | ||
| Q1 25 | 27.3% | -32.1% | ||
| Q4 24 | 16.4% | -34.8% | ||
| Q3 24 | 18.7% | -48.7% | ||
| Q2 24 | 23.8% | -81.6% |
每股收益（稀释后）CASHTARS
| Q1 26 | $3.35 | — | ||
| Q4 25 | $1.57 | $-0.17 | ||
| Q3 25 | $1.69 | $-0.30 | ||
| Q2 25 | $1.81 | $-0.48 | ||
| Q1 25 | $3.14 | $-0.64 | ||
| Q4 24 | $1.23 | $-0.57 | ||
| Q3 24 | $1.34 | $-0.61 | ||
| Q2 24 | $1.78 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $157.6M | $417.3M |
| 总债务越低越好 | $59.5M | $72.4M |
| 股东权益账面价值 | $850.7M | $343.4M |
| 总资产 | $7.1B | $562.2M |
| 负债/权益比越低杠杆越低 | 0.07× | 0.21× |
8季度趋势，按日历期对齐
现金及短期投资CASHTARS
| Q1 26 | $157.6M | — | ||
| Q4 25 | $331.2M | $417.3M | ||
| Q3 25 | $120.6M | $401.8M | ||
| Q2 25 | $258.3M | $381.1M | ||
| Q1 25 | $254.2M | $407.9M | ||
| Q4 24 | $597.4M | $291.4M | ||
| Q3 24 | $158.3M | $317.0M | ||
| Q2 24 | $298.9M | $323.6M |
总债务CASHTARS
| Q1 26 | $59.5M | — | ||
| Q4 25 | $33.5M | $72.4M | ||
| Q3 25 | $33.5M | $72.3M | ||
| Q2 25 | $33.4M | $72.1M | ||
| Q1 25 | $33.4M | $72.0M | ||
| Q4 24 | $33.4M | $71.8M | ||
| Q3 24 | $33.4M | $71.7M | ||
| Q2 24 | $33.3M | $71.6M |
股东权益CASHTARS
| Q1 26 | $850.7M | — | ||
| Q4 25 | $854.5M | $343.4M | ||
| Q3 25 | $858.0M | $335.1M | ||
| Q2 25 | $819.0M | $332.6M | ||
| Q1 25 | $814.7M | $342.5M | ||
| Q4 24 | $758.3M | $224.5M | ||
| Q3 24 | $822.5M | $237.5M | ||
| Q2 24 | $748.4M | $252.2M |
总资产CASHTARS
| Q1 26 | $7.1B | — | ||
| Q4 25 | $7.6B | $562.2M | ||
| Q3 25 | $7.2B | $534.6M | ||
| Q2 25 | $7.2B | $495.0M | ||
| Q1 25 | $7.0B | $500.8M | ||
| Q4 24 | $7.6B | $377.0M | ||
| Q3 24 | $7.5B | $376.3M | ||
| Q2 24 | $7.5B | $376.8M |
负债/权益比CASHTARS
| Q1 26 | 0.07× | — | ||
| Q4 25 | 0.04× | 0.21× | ||
| Q3 25 | 0.04× | 0.22× | ||
| Q2 25 | 0.04× | 0.22× | ||
| Q1 25 | 0.04× | 0.21× | ||
| Q4 24 | 0.04× | 0.32× | ||
| Q3 24 | 0.04× | 0.30× | ||
| Q2 24 | 0.04× | 0.28× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $19.3M |
| 自由现金流经营现金流 - 资本支出 | — | $13.0M |
| 自由现金流率自由现金流/营收 | — | 8.6% |
| 资本支出强度资本支出/营收 | — | 4.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-22.3M |
8季度趋势，按日历期对齐
经营现金流CASHTARS
| Q1 26 | — | — | ||
| Q4 25 | $108.3M | $19.3M | ||
| Q3 25 | $303.7M | $18.3M | ||
| Q2 25 | $30.4M | $-29.4M | ||
| Q1 25 | $188.3M | $-20.7M | ||
| Q4 24 | $-71.7M | $-22.2M | ||
| Q3 24 | $143.1M | $-8.7M | ||
| Q2 24 | $113.2M | $-14.4M |
自由现金流CASHTARS
| Q1 26 | — | — | ||
| Q4 25 | $104.1M | $13.0M | ||
| Q3 25 | $300.3M | $16.3M | ||
| Q2 25 | $27.7M | $-30.4M | ||
| Q1 25 | $184.7M | $-21.2M | ||
| Q4 24 | $-73.8M | $-22.3M | ||
| Q3 24 | $138.8M | $-8.9M | ||
| Q2 24 | $111.0M | $-15.4M |
自由现金流率CASHTARS
| Q1 26 | — | — | ||
| Q4 25 | 60.1% | 8.6% | ||
| Q3 25 | 160.9% | 13.8% | ||
| Q2 25 | 14.1% | -29.6% | ||
| Q1 25 | 67.2% | -27.1% | ||
| Q4 24 | -40.4% | -33.5% | ||
| Q3 24 | 77.3% | -18.6% | ||
| Q2 24 | 58.8% | -37.8% |
资本支出强度CASHTARS
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 4.2% | ||
| Q3 25 | 1.8% | 1.6% | ||
| Q2 25 | 1.4% | 1.0% | ||
| Q1 25 | 1.3% | 0.8% | ||
| Q4 24 | 1.1% | 0.1% | ||
| Q3 24 | 2.4% | 0.6% | ||
| Q2 24 | 1.2% | 2.5% |
现金转化率CASHTARS
| Q1 26 | — | — | ||
| Q4 25 | 3.08× | — | ||
| Q3 25 | 7.83× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 2.51× | — | ||
| Q4 24 | -2.39× | — | ||
| Q3 24 | 4.27× | — | ||
| Q2 24 | 2.52× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CASH
| Noninterest Income | $151.2M | 55% |
| Net Interest Income | $125.1M | 45% |
TARS
暂无分部数据
